These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 33832539)

  • 1. Hsp90 co-chaperones, FKBP52 and Aha1, promote tau pathogenesis in aged wild-type mice.
    Criado-Marrero M; Gebru NT; Blazier DM; Gould LA; Baker JD; Beaulieu-Abdelahad D; Blair LJ
    Acta Neuropathol Commun; 2021 Apr; 9(1):65. PubMed ID: 33832539
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hsp90 activator Aha1 drives production of pathological tau aggregates.
    Shelton LB; Baker JD; Zheng D; Sullivan LE; Solanki PK; Webster JM; Sun Z; Sabbagh JJ; Nordhues BA; Koren J; Ghosh S; Blagg BSJ; Blair LJ; Dickey CA
    Proc Natl Acad Sci U S A; 2017 Sep; 114(36):9707-9712. PubMed ID: 28827321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hsp90 regulates tau pathology through co-chaperone complexes in Alzheimer's disease.
    Salminen A; Ojala J; Kaarniranta K; Hiltunen M; Soininen H
    Prog Neurobiol; 2011 Jan; 93(1):99-110. PubMed ID: 21056617
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The FK506-binding protein FKBP52 in vitro induces aggregation of truncated Tau forms with prion-like behavior.
    Giustiniani J; Guillemeau K; Dounane O; Sardin E; Huvent I; Schmitt A; Hamdane M; Buée L; Landrieu I; Lippens G; Baulieu EE; Chambraud B
    FASEB J; 2015 Aug; 29(8):3171-81. PubMed ID: 25888602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decrease of the immunophilin FKBP52 accumulation in human brains of Alzheimer's disease and FTDP-17.
    Giustiniani J; Sineus M; Sardin E; Dounane O; Panchal M; Sazdovitch V; Duyckaerts C; Chambraud B; Baulieu EE
    J Alzheimers Dis; 2012; 29(2):471-83. PubMed ID: 22233767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Concomitant Neuronal Tau Deposition and FKBP52 Decrease Is an Early Feature of Different Human and Experimental Tauopathies.
    Meduri G; Guillemeau K; Daguinot C; Dounane O; Genet M; Ferrara L; Chambraud B; Baulieu EE; Giustiniani J
    J Alzheimers Dis; 2023; 94(1):313-331. PubMed ID: 37248902
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Caspase-cleaved Tau-D(421) is colocalized with the immunophilin FKBP52 in the autophagy-endolysosomal system of Alzheimer's disease neurons.
    Meduri G; Guillemeau K; Dounane O; Sazdovitch V; Duyckaerts C; Chambraud B; Baulieu EE; Giustiniani J
    Neurobiol Aging; 2016 Oct; 46():124-37. PubMed ID: 27479154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Small Heat Shock Protein 22 Improves Cognition and Learning in the Tauopathic Brain.
    Rodriguez Ospina S; Blazier DM; Criado-Marrero M; Gould LA; Gebru NT; Beaulieu-Abdelahad D; Wang X; Remily-Wood E; Chaput D; Stevens S; Uversky VN; Bickford PC; Dickey CA; Blair LJ
    Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35055033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FKBP52 overexpression accelerates hippocampal-dependent memory impairments in a tau transgenic mouse model.
    Criado-Marrero M; Gebru NT; Gould LA; Blazier DM; Vidal-Aguiar Y; Smith TM; Abdelmaboud SS; Shelton LB; Wang X; Dahrendorff J; Beaulieu-Abdelahad D; Dickey CA; Blair LJ
    NPJ Aging Mech Dis; 2021 May; 7(1):9. PubMed ID: 33941782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Imbalances in the Hsp90 Chaperone Machinery: Implications for Tauopathies.
    Shelton LB; Koren J; Blair LJ
    Front Neurosci; 2017; 11():724. PubMed ID: 29311797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The high-affinity HSP90-CHIP complex recognizes and selectively degrades phosphorylated tau client proteins.
    Dickey CA; Kamal A; Lundgren K; Klosak N; Bailey RM; Dunmore J; Ash P; Shoraka S; Zlatkovic J; Eckman CB; Patterson C; Dickson DW; Nahman NS; Hutton M; Burrows F; Petrucelli L
    J Clin Invest; 2007 Mar; 117(3):648-58. PubMed ID: 17304350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decrease of neuronal FKBP4/FKBP52 modulates perinuclear lysosomal positioning and MAPT/Tau behavior during MAPT/Tau-induced proteotoxic stress.
    Chambraud B; Daguinot C; Guillemeau K; Genet M; Dounane O; Meduri G; Poüs C; Baulieu EE; Giustiniani J
    Autophagy; 2021 Nov; 17(11):3491-3510. PubMed ID: 33459145
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isomerization and Oligomerization of Truncated and Mutated Tau Forms by FKBP52 are Independent Processes.
    Kamah A; Cantrelle FX; Huvent I; Giustiniani J; Guillemeau K; Byrne C; Jacquot Y; Landrieu I; Baulieu EE; Smet C; Chambraud B; Lippens G
    J Mol Biol; 2016 Mar; 428(6):1080-1090. PubMed ID: 26903089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Accelerated neurodegeneration through chaperone-mediated oligomerization of tau.
    Blair LJ; Nordhues BA; Hill SE; Scaglione KM; O'Leary JC; Fontaine SN; Breydo L; Zhang B; Li P; Wang L; Cotman C; Paulson HL; Muschol M; Uversky VN; Klengel T; Binder EB; Kayed R; Golde TE; Berchtold N; Dickey CA
    J Clin Invest; 2013 Oct; 123(10):4158-69. PubMed ID: 23999428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tau Ser208 phosphorylation promotes aggregation and reveals neuropathologic diversity in Alzheimer's disease and other tauopathies.
    Xia Y; Prokop S; Gorion KM; Kim JD; Sorrentino ZA; Bell BM; Manaois AN; Chakrabarty P; Davies P; Giasson BI
    Acta Neuropathol Commun; 2020 Jun; 8(1):88. PubMed ID: 32571418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Crystal Structure of the Hsp90-LA1011 Complex and the Mechanism by Which LA1011 May Improve the Prognosis of Alzheimer's Disease.
    Roe SM; Török Z; McGown A; Horváth I; Spencer J; Pázmány T; Vigh L; Prodromou C
    Biomolecules; 2023 Jun; 13(7):. PubMed ID: 37509087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular chaperones and regulation of tau quality control: strategies for drug discovery in tauopathies.
    Miyata Y; Koren J; Kiray J; Dickey CA; Gestwicki JE
    Future Med Chem; 2011 Sep; 3(12):1523-37. PubMed ID: 21882945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular chaperone-mediated tau protein metabolism counteracts the formation of granular tau oligomers in human brain.
    Sahara N; Maeda S; Yoshiike Y; Mizoroki T; Yamashita S; Murayama M; Park JM; Saito Y; Murayama S; Takashima A
    J Neurosci Res; 2007 Nov; 85(14):3098-108. PubMed ID: 17628496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of the interaction of Aha1 with components of the Hsp90 chaperone machine and client proteins.
    Sun L; Prince T; Manjarrez JR; Scroggins BT; Matts RL
    Biochim Biophys Acta; 2012 Jun; 1823(6):1092-101. PubMed ID: 22504172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aha1 can act as an autonomous chaperone to prevent aggregation of stressed proteins.
    Tripathi V; Darnauer S; Hartwig NR; Obermann WM
    J Biol Chem; 2014 Dec; 289(52):36220-8. PubMed ID: 25378400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.